ABBV Earnings: AbbVie experiences decrease adj. revenue for Q1 2024; income edges up
Specialty biopharmaceutical firm AbbVie, Inc. (NYSE: ABBV) Friday introduced first-quarter 2024 monetary…
By
admin
Specialty biopharmaceutical firm AbbVie, Inc. (NYSE: ABBV) Friday introduced first-quarter 2024 monetary…
Sign in to your account